ReviewDer Radiologe2022
[Low-field magnetic resonance imaging : Just less expensive or completely different?]
Review in Der Radiologe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the years the development of field strength in magnetic resonance imaging (MRI) has continued to increase from the low-field systems in the early years (0.2-0.5 T) to 1.5 T to 3 T to 7 T and more. In the last 2 years, there has been a renewed interest in MRI at lower fields, mainly driven by the development of "dry" superconductive magnets. The following article demonstrates that this renewed interest for lower fields is not a déjà vu purely driven by economic needs. The field strength appears to be from yesterday, but the combination with the tremendous improvements and innovations of all relevant components-gradients, radiofrequency system and especially new algorithms including the use of artificial intelligence (AI)-allow the realization of diagnostically adequate MRI without compromise in patient throughput and efficiency. In addition to the lower field, there are also some inherent advantages, e.g., for MRI of the lung and of metallic implants and especially for interventional MRI. It has already been shown that many of the devices used for interventional procedures (catheters, biopsy needles) can be used at lower fields without costly modifications. In addition, low-field MRI also allows the robust use of highly efficient sampling methods like spiral MRI. It is therefore safe to predict that low-field MRI is not only a cost-efficient compromise, but has the potential to open up new fields of application.
Indexed as
Identifiers
35258684What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.